TELO READ THE FULL TELO RESEARCH REPORT Telomir Pharmaceuticals (NASDAQ:TELO) is a preclinical stage biopharmaceutical company developing a product designed to lengthen the DNA’s protective telomere ...

Telomir Pharmaceuticals (NASDAQ:TELO) is a preclinical stage biopharmaceutical ... a preclinical study of Telomir-1 on human retinal cell lines. Data from the test showed the ability of Telomir ...

Telo completed first drivable prototype of its planned MT1 pickup, having already launched a configurator and having started accepting deposits. The truck promises over 350 miles of range and up ...

Telo wants to be the cure for the bloated trucks we see today. The company is promising to provide big-truck utility in a package no longer than a Mini Cooper. Now, we're finally getting a look at ...

A few interesting startups are beginning to make the most of this moment. California-based Telo Trucks is one of the more notable examples of this trend. Its MT1 truck aims to be the antidote to ...

Telo has raised some US$6.8 million over the last couple of years with its vision to build a compact, performance electric truck with a full-size bed and the footprint of a Mini Cooper SE. The ...

Rodman & Renshaw analyst Elemer Piros initiated coverage with a Buy rating on Telomir Pharmaceuticals, Inc. (TELO – Research Report) yesterday and set a price target of $15.00. The company’s ...